• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺原位癌:组织病理学与免疫组化标志物及DNA倍体的相关性

Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy.

作者信息

Ottesen G L, Christensen I J, Larsen J K, Larsen J, Baldetorp B, Linden T, Hansen B, Andersen J

机构信息

Department of Forensic Pathology, University of Copenhagen.

出版信息

Breast Cancer Res Treat. 2000 Apr;60(3):219-26. doi: 10.1023/a:1006453420088.

DOI:10.1023/a:1006453420088
PMID:10930109
Abstract

In a consecutive and unselected series of 178 cases of carcinoma in situ of the breast (CIS), comprising both ductal (DCIS) and lobular type (LCIS), and a series of 48 cases of invasive carcinoma (IC) with predominance of DCIS, the association between histopathology, immunohistochemical markers (ER, PgR, MIB-1, c-erbB-2, and p53), and DNA ploidy was investigated, in order to discriminate biologically different groups. In DCIS, significant correlation was shown between large nuclear size and comedonecrosis, both of which showed also strong association to DNA aneuploidy, high proliferation activity, low steroid receptor content, and overexpression of c-erbB-2 and p53 factors that may indicate an aggressive behavior. Small nuclear CIS, whether LCIS or DCIS, on the contrary, were DNA diploid with low proliferation, and no cases showed overexpression of c-erbB-2 and p53. Heterogeneity with respect to the investigated parameters was also a frequent finding that may reflect a development complexity. In IC, comparison of the DCIS and the invasive component showed similar patterns. No significant differences were shown between DCIS without and with invasion. This may indicate that none of the investigated parameters on its own are essential for the event of invasion.

摘要

在一组连续且未经筛选的178例乳腺原位癌(CIS)病例中,包括导管原位癌(DCIS)和小叶原位癌(LCIS),以及一组以DCIS为主的48例浸润性癌(IC)病例中,研究了组织病理学、免疫组化标志物(ER、PgR、MIB-1、c-erbB-2和p53)与DNA倍体之间的关联,以区分生物学上不同的组。在DCIS中,细胞核大与粉刺样坏死之间存在显著相关性,二者均与DNA非整倍体、高增殖活性、低类固醇受体含量以及可能表明侵袭性行为的c-erbB-2和p53因子过表达也密切相关。相反,小细胞核CIS,无论是LCIS还是DCIS,均为DNA二倍体,增殖率低,且无病例显示c-erbB-2和p53过表达。在所研究参数方面的异质性也是一个常见发现,这可能反映了其发展的复杂性。在IC中,DCIS与浸润成分的比较显示出相似的模式。有浸润和无浸润的DCIS之间未显示出显著差异。这可能表明所研究的参数单独一项对于浸润事件都不是必需的。

相似文献

1
Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy.乳腺原位癌:组织病理学与免疫组化标志物及DNA倍体的相关性
Breast Cancer Res Treat. 2000 Apr;60(3):219-26. doi: 10.1023/a:1006453420088.
2
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.
3
Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein.乳腺导管原位癌。组织学分类及其与激素受体、p53和c-erbB-2蛋白的倍性及免疫组化表达的关系。
Cancer. 1995 Apr 15;75(8):2123-31. doi: 10.1002/1097-0142(19950415)75:8<2123::aid-cncr2820750815>3.0.co;2-v.
4
p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast.乳腺导管原位癌和小叶原位癌中的p53蛋白表达、细胞增殖及甾体激素受体
Eur J Cancer. 1997 Jan;33(1):39-44. doi: 10.1016/s0959-8049(96)00368-1.
5
Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.病理学观点。乳腺导管原位癌:关于一种新的简化组织学分类以及细胞增殖与c-erbB-2蛋白表达之间关联的提议。
Mod Pathol. 1994 Feb;7(2):257-62.
6
Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.乳腺小叶原位癌、导管原位癌及相关浸润性癌的遗传关系。
Mol Pathol. 2000 Jun;53(3):118-21. doi: 10.1136/mp.53.3.118.
7
Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma.nm23基因产物在非侵袭性乳腺癌中的异质性表达。
Cancer. 1994 May 1;73(9):2352-8. doi: 10.1002/1097-0142(19940501)73:9<2352::aid-cncr2820730918>3.0.co;2-x.
8
Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast.雌激素受体阴性作为乳腺高级别导管原位癌的一个标志物。
Histopathology. 2003 May;42(5):440-7. doi: 10.1046/j.1365-2559.2003.01612.x.
9
Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.乳腺多形性小叶(导管-小叶)原位癌的临床、组织病理学及生物学特征:24例报告
Mod Pathol. 2002 Oct;15(10):1044-50. doi: 10.1097/01.MP.0000027624.08159.19.
10
Is there a low-grade precursor pathway in breast cancer?乳腺癌是否存在低度恶性前体途径?
Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.

引用本文的文献

1
Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ.基底细胞角蛋白作为导管原位癌低侵袭风险的潜在标志物。
Clinics (Sao Paulo). 2013 May;68(5):638-43. doi: 10.6061/clinics/2013(05)010.
2
Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression.基于患者校准的导管原位癌(DCIS)的代理建模:从微观测量到临床进展的宏观预测。
J Theor Biol. 2012 May 21;301:122-40. doi: 10.1016/j.jtbi.2012.02.002. Epub 2012 Feb 9.
3
Biologic characteristics of premalignant breast disease.
癌前乳腺疾病的生物学特性。
Cancer Biomark. 2010;9(1-6):177-92. doi: 10.3233/CBM-2011-0187.